- 期刊
從實證醫學討論Ursodeoxycholic Acid使用於慢性肝病之爭議
The Disputes on Ursodeoxycholic Acid for Chronic Liver Diseases: Evidence-Based Analysis
延伸閱讀
- 高嘉宏（2013）。淺談藥物性肝炎。健康世界，(336)，28-31。https://www.airitilibrary.com/Article/Detail?DocID=16077059-201312-201402070015-201402070015-28-31
- 高嘉宏、陳定信（1995）。慢性肝炎之新分類：強調病因、發炎活性分級和纖維化分期之觀念。當代醫學，(261)，529-534。https://doi.org/10.29941/MT.199507.0002
- 衛生署全民健康保險爭議審議委員會（2005）。肝炎病患使用肝庇護劑之爭議。台灣醫學，9(2)，232-234。https://doi.org/10.6320/FJM.2005.9(2).13
- Hsu, C. J. (2014). Prospective Analysis of Small Metabolites and Obesity-Related Liver Disease in Hepatitis B [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2014.00052
- 賴世偉、廖光福、黃金財（2005）。Analysis of Nonalcoholic Fatty Liver in Patients Receiving Health Checkups: A Hospital-Based Study。輔仁醫學期刊，3(2)，75-80。https://www.airitilibrary.com/Article/Detail?DocID=18102093-200506-3-2-75-80-a